Final assessment on commercialisation risks

This week, health editor Michael Smith on why baby-making is such big business and how private equity firms are reshaping the IVF sector.

This podcast is sponsored by Acenda 

Further reading:
Ill-conceived: Inside Australia’s IVF money-making machine
The commercialisation of the industry as private equity owners take over from pioneering doctors has many people very worried.
Monash IVF rejects $300m takeover bid from Genesis Capital as too low
Shares in the fertility group have fallen more than 40 per cent since mistakes were disclosed earlier this year, prompting the PE-led consortium to swoop.
Monash IVF says market share, patients down since embryo mix-ups
Stiff competition and pricing pressure in Victoria has hurt the fertility group’s performance so far this fiscal year.

See omnystudio.com/listener for privacy information.